Skip to main content
Download PDF

mRNA expression analysis of the hippocampus in a vervet monkey model of fetal alcohol spectrum disorder

Journal of Neurodevelopmental Disorders volume 14, Article number: 21 (2022) Cite this article

Abstract

Background

Fetal alcohol spectrum disorders (FASD) are common, yet preventable developmental disorders that stem from prenatal exposure to alcohol. This exposure leads to a wide array of behavioural and physical problems with a complex and poorly defined biological basis.

Molecular investigations to date predominantly use rodent animal models, but because of genetic, developmental and social behavioral similarity, primate models are more relevant. We previously reported reduced cortical and hippocampal neuron levels in an Old World monkey (Chlorocebus sabaeus) model with ethanol exposure targeted to the period of rapid synaptogenesis and report here an initial molecular study of this model. The goal of this study was to evaluate mRNA expression of the hippocampus at two different behavioural stages (5 months, 2 years) corresponding to human infancy and early childhood.

Methods

Offspring of alcohol-preferring or control dams drank a maximum of 3.5 g ethanol per kg body weight or calorically matched sucrose solution 4 days per week during the last 2 months of gestation. Total mRNA expression was measured with the Affymetrix GeneChip Rhesus Macaque Genome Array in a 2 × 2 study design that interrogated two independent variables, age at sacrifice, and alcohol consumption during gestation.

Results and discussion

Statistical analysis identified a preferential downregulation of expression when interrogating the factor ‘alcohol’ with a balanced effect of upregulation vs. downregulation for the independent variable ‘age’. Functional exploration of both independent variables shows that the alcohol consumption factor generates broad functional annotation clusters that likely implicate a role for epigenetics in the observed differential expression, while the variable age reliably produced functional annotation clusters predominantly related to development. Furthermore, our data reveals a novel connection between EFNB1 and the FASDs; this is highly plausible both due to the role of EFNB1 in neuronal development as well as its central role in craniofrontal nasal syndrome (CFNS). Fold changes for key genes were subsequently confirmed via qRT-PCR.

Conclusion

Prenatal alcohol exposure leads to global downregulation in mRNA expression. The cellular interference model of EFNB1 provides a potential clue regarding how genetically susceptible individuals may develop the phenotypic triad generally associated with classic fetal alcohol syndrome.

Background

The effect of alcohol consumption in utero was first documented in the modern era between 1968 and 1973 based on a cohort of children that all shared a specific pattern of cranio-facial dysmorphology, central nervous system defects and growth deficiency which led to the initial phenotypic characterization of fetal alcohol syndrome (FAS) [1, 2]. As time progressed, it became evident that the criteria for FAS were too restrictive and did not capture the full range of effects that pre-natal ethanol exposure might induce in a developing child. This led the nosology through a series of updates until the term fetal alcohol spectrum disorders (FASD) was created to satisfy the full range of damaging effects that alcohol may have on a developing embryo [3]. The major risk factors for developing clinical FASD appear to be a combination of the gestational timing of ethanol exposure, degree of ethanol exposure [4], and a genetic predisposition to the effects of prenatal alcohol exposure (PAE) [5,6,7,8]. The diverse nature and stochasticity of these risk factors coupled with the lack of full compliance limits the ability of public health agencies to rely exclusively on information campaigns to prevent this disorder. As a result, attention and focus must be placed on understanding its development from a molecular perspective to generate an alternate route of intervention.

A promising strategy to identify the impact of PAE on neurodevelopment involves the use of gene expression analysis in model organisms. Several studies utilizing this strategy have implicated a wide variety of genes and a diverse array of cellular processes without the clear emergence of an underlying consistency [9,10,11,12,13,14,15,16,17,18,19,20,21]. The wide range of cellular processes implicated in these various studies likely stems, at least in part, from the very high number of study design combinations (different organisms, amount, pattern and gestational timing of exposure, tissues interrogated, and acute vs temporally delayed measurement). These combinations in study designs may yield valuable yet distinct results that are difficult to assimilate into a coherent picture of such a heterogeneous disorder. This diversity and lack of a clear molecular pathway may also not be surprising given that ethanol appears to have relatively non-specific, sometimes transient, low affinity interactions with its targets as opposed to compounds with a specific binding domain represented in a single peptide family [22]. The level of clinical heterogeneity observed in patients with FASD would be expected given range of gene expression effects in animal models of FASD, yet amongst the clinical heterogeneity are several re-emerging phenotypes that enabled the initial characterization of FAS and FASD.

The hippocampus is a particularly relevant structure to examine due to the well documented effects that ethanol exerts in this vulnerable region both pre- and postnatally. Early studies showed a reduction in the number of dendrite arborizations in the hippocampus after long-term alcohol abuse [23]. Others have shown that there is a reduction in the number of glial cells in the hippocampus of chronic alcohol abusers [24]. The adolescent brain shows increased hippocampal neurotoxicity related to alcohol consumption [25] and it has also been shown that hippocampal volume is decreased in adolescents with chronic exposure to alcohol [26,27,28]. There have been several reports of increased cell death and decreased volume in the hippocampus due to PAE in rodents [29, 30] and guinea pigs [31]. In addition, our group has previously reported significant numerical reductions in the principal hippocampal neurons of C. sabaeus offspring with moderate levels of PAE during the period of rapid synaptogenesis [32]. In these animals, the neuronal deficits are present neonatally, persist through infancy (5 months) and increase in juvenile (2 years) stages.

There are several advantages to using this same non-human primate as the model organism in which to study hippocampal mRNA expression changes. First, it allows a simulation of the broader effects observed in FASD in a model organism with developmental trajectory that closely parallels that of humans but is temporally faster. In addition, a substantial proportion (but not all) of the St. Kitts C. sabaeus monkeys voluntarily drink moderate or even large quantities of beverage in the absence of dietary restrictions or behavioral training, with population level variance ranging from pathological to abstinent similar to that observed in human studies [33].

With respect to the phenotype of animals included in this study, our goal was explicitly to model the changes that would occur during the period of active synaptogenesis. Accordingly, these PAE offspring have neither facial dysmorphologies nor growth retardation. Behaviors characteristic of social dysfunction can be identified as early as 5 months of age, but cognitive impairment (as measured by object retrieval testing) is not robustly identified until 3 or 4 years of age. A more sensitive early measure is neuronal number in PAE offspring as compared to controls. All PAE animals used in this study had alcohol exposure (both absolute levels and developmental periods) shown in our anatomical studies to produce a 40% reduction in frontal cortical neurons [34] and nearly 60% reduction in CA1 hippocampal neurons at 2 years of age [32]. These characteristics allow us to unite the features that are more applicable to humans regarding this disorder yet still enable the controlled manipulation of key experimental variables. Using this primate model, we interrogated the mRNA expression of the entire hippocampus in both PAE and control individuals using GeneChip microarray technology. These characteristics allow us to unite the features that are more applicable to humans regarding this disorder yet still enable the controlled manipulation of key experimental variables. Using this primate model, we interrogated the mRNA expression of the entire hippocampus in both PAE and control individuals using genechip microarray technology.

Methods

Animal care

Male vervet monkeys of two age categories [5 months infants (mean 5.6 months ± 0.87 months); 2-year juveniles (mean 26.4 months ± 2.68 months)] and two conditions (FASD, control) were selected for this study (GSE173516). Male vervets were examined exclusively in order to eliminate any biological variance related to sex [33, 35, 36]. All animals were captive-bred under the care of the Behavioural Science Foundation (St. Kitts, Eastern Caribbean) and housed within outdoor social enclosures in a setting that resembles their natural environment with regular foraging opportunities. These subjects were fed with High-protein Primate Chow (Harlan, USA) and local produce with unlimited access to clean drinking water. To avoid the stress of forced alcohol administration, only alcohol preferring dams were used in this study.

All procedures in this study were reviewed and approved by the Animal Care Committee of McGill University (Montreal, Canada, protocol #4627) and assented to by the Animal Care Committee of Behavioural Science Foundation (BSF 1103, 1301), both acting under the auspices of the Canadian Council on Animal Care. Behavioural Science Foundation conducts research using standard operating procedures for all in vivo procedures described in this study.

Alcohol exposure

As noted in the abstract, many St. Kitt’s vervets will voluntarily drink intoxicating amounts of beverage alcohol [36]. However, this propensity is not universal, and population studies indicate that the prevalence of alcohol preference in C. sabaeus closely mimics that seen in human populations [34]. Specifically, about 25% of the population will voluntarily drink to intoxication and approximately 5% drink abusively. Prior to the present study, adult females that would drink at least 2 g of beverage ethanol in a 4-h scheduled access period were identified, using a two-choice bottle method previously described [37], all specific data related to age and exposure is available in the online data [https://doi.org/10.5061/dryad.g1jwstqqz]. Social groups comprising 5–6 alcohol preferring dams, as defined above, were housed with a single alcohol avoiding male. Once group stability had been established, groups were observed for evidence of menstrual cycling and reproductive behaviour. At approximately 1 month after breeding was observed, females were examined, and the uterus was measured and palpated for evidence of pregnancy. Animals that were pregnant were shave-marked for rapid identification, and gestational stage was followed by semi-weekly physical examinations. Alcohol was presented to selected dames 56 to 77 (mean 67 ± 8) days prior to the birth of full-term infants. During the alcohol administration period, the door between the main cage and the drinking compartment was opened, and the dam either walked directly into the drinking compartment or was encouraged to do so by presentation of a piece of banana or other fruit. Pregnant dams were then offered either an ethanol solution (PAE condition: 8% w/v ethanol in tap water) or an equal volume of isocaloric sucrose with no ethanol (control condition). The same alcohol-preferring females might be offered ethanol during one breeding cycle, and sucrose during the next, or vice versa. Tap water was freely available to all animals at all times. Volumes of the ethanol solution were varied so that each alcohol exposed mother would be allowed to drink no more than 3.5 g ethanol per kg body weight in a single session. At the end of the 4-h exposure period, all animals were returned to the social group. A small amount of blood was collected from both alcohol-drinking and control dams trained to present a leg for unanesthetized blood collection every 2 weeks for the measurement of blood alcohol concentration.

Tissue collection

Age-matched cases and controls were scheduled for sequential sacrifice and moved from social groups to individual cages several days prior to sacrifice in order to minimize environmental sources of variance. Animals were sacrificed between 10 am and noon to minimize variance related to circadian oscillation. Sacrifice occurred under ketamine anesthesia, using an American Veterinary Medical Association-approved pentobarbital solution to minimize distress [38]. Furthermore, animals from within each group were randomly assigned a sacrifice order with an alternation between cases and controls. Brains were perfused with ice-cold RNAse-free phosphate-buffered saline, rapidly removed, and dissected with sterile instruments rinsed in sterile RNAse-free phosphate buffered saline. The left hippocampus was removed subsequent to a saggital cut through the brain separating the left and right hemispheres and transferred to a sterile vial containing 1 ml Guanidine isothiocyanate/phenol solution (Qiazol–Qiagen, Germany) for each 100 mg of tissue. The tissue was immediately homogenized using a portable homogenizer (Tissue Master 125–Omni, USA). Aliquots (1 ml) were transferred to sterile cryovials and frozen at – 40 °C prior to dry-ice shipment to Montreal for further processing and analysis.

RNA preparation

Total RNA was extracted from the frozen homogenate using the Qiagen miRNeasy kit (Qiagen, Germany), under RNAse-free conditions, following the manufacturer’s protocol. These samples were then transferred to the McGill University and Genome Quebec Innovation Center (Montreal, Canada) for quality analysis and microarray hybridization. Purified total RNA (miRNA and mRNA) was analyzed for concentration using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, USA) and quality using the Bioanalyzer 2100 (Agilent, USA). The RNA integrity number (RIN) number is influenced by low oligomer length miRNAs and therefore the quality was assessed by combining high RIN numbers with a steady baseline and distinct spikes for each RNA species (miRNA, 18s,28s) while examining the electropheretograms generated by the 2100 system. Furthermore, complementary RNA (cRNA) quality was also assessed using the Agilent Bioanalyzer and all cRNA samples used in the final study passed this stage of quality control as well. A total of 32 male vervet RNA samples were screened with 24 selected for final array hybridization based on preferred sample quality. These 24 samples were equally divided between each of four groups: 6 (5-month FASD), 6 (5-month control), 6 (2-year FASD), and 6 (2-year control).

Array hybridization, quality control, analysis

Samples were hybridized to Affymetrix GeneChip Rhesus Macaque Genome Arrays at the McGill University-Genome Quebec Innovation Center (MUGQIC). The RNA samples were all loaded onto the arrays on the same day, in a random manner with respect to biological grouping. The array data were then examined for evidence of RNA degradation using the AffyRNAdeg function in the Bioconductor package [39] developed for the open-sourced software environment R (www.R-project.org) (Supplemental Figure 1). The raw data was normalized using the robust multi-array average (RMA) normalization method [40]. These data were also explored further with the FlexArray software package [41] developed at the MUGQIC. All arrays passed initial quality control however, as evidenced by 3D principal components analysis (Supplemental Figures 2, 3), two arrays displayed strong outlier profiles (one 5-month FASD and one 2-year FASD) and were eliminated from further analysis. The final sample thus had an unbalanced 2 × 2 design with 22 arrays.

Probe filtering

Probe sets that could not be annotated were filtered out using combined information from the available Affymetrix annotation and the private annotation developed by the Norgren lab at the University of Idaho. This reduced the number of probe sets from 52,866 to 24,402. The remaining probe sets were further reduced using the MAS 5.0 Absolute Detection function in the Affymetrix array suite for R [42], such that only probe sets that showed significant expression levels (p value < 0.05) in at least 6 arrays were included for further analysis. This reduced the number of probe sets from 24,402 to 17,652. Following this, genes for which multiple probe sets were present were reduced to minimize the number of tests performed by selecting the probe set with the highest mean expression level across all arrays. This method was chosen given the nature of cross species hybridization as well as the unreliable nature of many of the additional probe sets on the array [43]. This reduced the total number of probe sets corresponding to unique genes to 11,512. These 11,512 annotated, expressed and unique gene entries were carried forward for statistical analysis.

Statistical analysis

Consistent with the research design, these retained datasets were analyzed using a two-way analysis of variance (ANOVA), with two main factors (alcohol, age) each with two levels (5 month/2 years, FASD/control). The analysis strategy was carefully conceived a priori, and the gene annotations were not consulted until we were satisfied these data had been properly analyzed. This is a subtle distinction that ensured we would not analyze these data via multiple avenues before selecting the results which produced the most pleasing results. Constrained exploration of the array was performed by creating a narrowed subset of genes of interest a priori (the candidate pool) which was assigned q-values separately from the general pool in order to minimize the difficulties associated with multiple comparisons [44]. This method of constrained exploration was only utilized for the independent variable of interest (alcohol) to increase our ability to detect important and relevant signals. The p values were converted to q values as a means to represent the false discovery rate given the number of tests performed within this study [45]. The q value is a useful algorithm to correct for multiple testing given that with traditional FDR cannot be defined when there are no positive results. A recent update to this algorithm using an additional informative variable approach is available for processes such eQTL mapping or RNA-seq data where an additional variable such as read depth can enhance the overall amount of information available to calculate these q values [46]. The remaining genes (the general pool) were still examined to avoid ignoring potentially important surprise findings; however, their q values [45] were calculated independently from those of the candidate pool. The candidate pool was chosen a priori after reviewing gene ontology (GO) terms with high probability of involvement in the FASD phenotype (retinoic acid signalling, WNT signalling, CNS development, synaptic transmission, maturation, establishment, axon guidance, netrin receptor activity, cholesterol homeostasis, activator of MAPK activity, caspase activity), and included genes that were identified as differentially expressed in previous studies of FASD that had been performed prior to 2013.

qRT-PCR

Five differentially expressed genes were selected from the two independent variables; [EFNB1, GGCT (alcohol) and GBPB1L1, RHPLN1, SOX4 (age)] as a means to validate the array data. Primers for amplification were developed using genomic sequence data from Chlorocebus sabaeus, the model organism used within this study. The sequences used for amplification are listed in Supplemental Table 1. The mean values of ACTB were used to generate delta Ct values. RNA quality and cDNA quality were analyzed using the Bioanalzyer 2100 (Agilent, USA) at the Institut de Recherche en Cancerologie et Immunologie (IRIC, Montreal, Que). The qRT-PCR reactions were executed on the Illumina HiSeq 2000 using a TaqMan assay design with a no-reverse transcriptase and H2O as negative controls. The 2–∆∆Ct method was used to calculate fold changes in FASD animals relative to controls for EFNB1 and GGCT and 5 months relative to 2 years for SOX4, GBPB1L1 and RHPN2.

Functional annotation

Functional annotation was performed using the database for annotation, visualization and discovery (DAVID, v 6.8) by creating a custom background of total expressed genes from our tissue and a differentially expressed gene list with a p value threshold of 0.016 corresponding to a total of 297 genes from both the candidate and general pools. This gene list was created using the lowest raw p values from both candidate and general pools to avoid introducing a tautology to the gene list based on our a priori screening. The Entrez gene ID was used for both the differentially expressed gene list as well as the custom background. Functional annotation clustering was performed using the gene ontology (GO) term FAT selected to eliminate broad matches. The process was repeated using age as an independent variable using the same number of differentially expressed genes (297) to compare the output between our two variables.

Results

The study design enabled the exploration of two independent variables (age, alcohol) as well as their interaction. The overall data pattern of the arrays revealed very high pairwise correlation between arrays with a minimum of 0.94 and a mean of 0.97 with low variance and low overall fold changes for both of our experimental factors (age, alcohol) indicating that we managed to control many sources of external variance. A table of mean expression and mean variance is available as Supplemental Table 2. These fold changes are low in comparison with microarray studies where the phenotype (e.g., cancer) is more severe or in cases where it is possible to compare diseased tissue to normal tissue from the same individual. Despite the low distinction between groups and the strong correlation between the arrays, it is clear from a histogram of p values (Supplemental Figures 5 and 6) that each of our independent variables produced a notable within group effect on gene expression that differs from the null hypothesis.

Independent variable: alcohol

Exploring the effect of alcohol as an independent variable, there were 938 (116 from candidate, 822 general pool) total genes with a p value < 0.05, as compared to the 575 genes with a p value < 0.05 expected under the null hypothesis (Supplemental Figure 5). The p value for this departure in expected vs observed number of genes in this range is 3.6 × 10−54. This represents an over representation of 363 genes that have p values in this range. Specific exclusion of false positives is rendered difficult given the number of tests performed within an array where over 11,000 genes will be interrogated. This challenge was anticipated and led us to create a candidate gene list a priori for alcohol as an independent variable which pared the number of tests within that cohort of genes. Therefore, q values within this a priori candidate gene list were calculated independently of the remaining genes that were listed within a general pool. Of the 938 genes that achieved p < 0.05 for alcohol, 618 were down regulated and 320 were upregulated (Fig. 1) which is inconsistent with a 50/50 distribution (p value = 2.24 × 10−22). This is in contrast with the balanced number of differentially expressed upregulated and downregulated genes influenced by age indicating that excess downregulation was specific to alcohol. Overall, the data pattern supported a role for the probe set corresponding to EFNB1 within the candidate pool having an outsized effect relative to the background, with a q value of 0.0297 (p value 2.27 × 10−5). The gene with the next lowest p value of 4.3 × 10−5 corresponds to GGCT (q value of 0.26) which had been initially identified in the general pool. The third lowest was LINC476, a locus that does not code protein.

Fig. 1
figure 1

Volcano plot displaying the relationship between fold change (log2) and p-value (-log10) for all probe sets from both the a priori candidate pool and the general pools using Alcohol as an independent variable between pregnant vervet dams which voluntarily consumed alcohol between e100-165 and their sucrose matched controls. There was an overabundance of down regulated genes vs upregulated genes exploring the effect of alcohol. EFNB1 had the lowest p-value on the array and is identified at the top of the figure

Full size image

The expression profile was higher for EFNB1 in both 5-month and 2-year-old monkeys exposed to alcohol in utero as seen in Fig. 2. The p value for the interaction effect between age and alcohol was low (0.09) but not significant indicating that the upregulation of EFNB1 remained relatively constant as the monkeys continued through this period of development.

Fig. 2
figure 2

This figure shows the box plots of log2 expression intensity for EFNB1 across the four study groups within this data set showing the mean log2 expression of EFNB1 is higher in alcohol exposed monkeys relative to their sucrose matched controls. The interaction effect for ENFB1 was not significant

Full size image

Pathway exploration and functional annotation was performed on the 297 genes with the lowest p value on the array using the DAVID functional annotation tool. The full table of results can be found in the supplemental data files that are accessible online however the two annotation clusters with the highest enrichment scores are presented in Table 1.

Table 1 Top two functional annotation clusters generated from a list of 297 genes using alcohol as a independent variable with a p-value cut-off below 0.016
Full size table

Independent variable: age

Examining the effect of age on gene expression, we generally observed much lower q values in comparison to the alcohol phenotype, and a greater number of genes which display a p value less than 0.05. The number of genes below this threshold totalled 1055 (H0 = 575), revealing an additional 480 genes than would be expected under the null hypothesis. In contrast with alcohol as an independent variable, there was a relative balance between upregulated and down regulated genes with 534 downregulated and 521 upregulated. The volcano plot below displays the relationship between fold change and p value for all mRNAs interrogated in this study using alcohol as an independent variable (Fig. 3).

Fig. 3
figure 3

Volcano plot displaying relationship of p-values with fold changes using Age as an independent variable. Each dot represents a gene which has been plotted against the -log 10 of its p-value (vertical axis) and log 2 fold change (horizontal axis). There is a relative balance between up-regulated genes and down regulated genes using Age as an independent variable

Full size image

We also performed functional annotation clustering by creating a gene list of 297 genes with the lowest p values using age as an independent variable (Supplemental data files). In general, the q values for these genes were lower ranging from 0.0189 to 0.3 as opposed to 0.297–0.49 in the case of alcohol as an independent variable with a far greater number of genes with q values below 0.2. Eight of the top 15 annotation clusters were related to development or cell migration with gene ontology (GO) producing lower p values than those which were observed using alcohol as an independent variable (Supplemental Table 3).

In addition, the study design allows for the exploration of an interaction effect between age and alcohol which is a powerful method of identifying expression changes related to alcohol exposure that change through time. The interaction between age and alcohol resulted in slightly fewer than 5% of the probe sets with p values less than 0.05 with no probe sets having significant q values indicating that precise identification of differentially expressed genes which are influenced by alcohol in a manner that changes between 5 months and 2 years is either non-existent or buried within the background noise and unable to be identified without greater statistical power (Supplemental Figure 7). In addition, there were no genes within the interaction term whose q values distinguished themselves in a manner that would enable a prudent identification. Therefore, the interaction term was not explored further.

qRT-PCR

Five genes were chosen to validate the gene expression results via their correlation to a qRT-PCR platform. The genes were selected based on their low p-values using either alcohol or age as an independent variable. The two genes that were selected based on their low p values using alcohol as an independent variable were EFNB1 and GGCT. Three genes using age as an independent variable were selected GBP1L1, RHPN2, and SOX4. The 2–∆∆Ct method was used to calculate the fold changes corresponding to these genes which can be contrasted with fold changes calculated from the Rhesus GeneChip microarray in Fig. 4. Fold changes were low overall using both age and alcohol as seen in the volcano plots in Figs. 2 and 3 with SOX4 showing the greatest fold change among the genes interrogated via qRT-PCR and among the genes with the largest fold change using both age and alcohol on the array overall. GBPB1L1, a gene selected due to its low p value using age as an independent variable reveals a discrepancy in the fold change and direction between the array and the qRT-PCR. It displayed an inverse correlation with the array and furthermore, the -deltaCt vs log2 expression plot (Supplemental Figure 8) implied that the primers bound to the vervet genome at an alternate location. Aside from GPBP1L1 the fold changes between the array data and the qRT-PCR data were in concordance with each other.

Fig. 4
figure 4

Fold change comparison between data from the GeneChip microarray and qRT-PCR for 5 selected genes. Two genes showing significance for alcohol (EFNB1, GGCT) and three genes for Age (SOX4, RHPN2, GBPB1L1)

Full size image

Discussion

This study design resulted in four primary identifications: (1) the functional annotation of clusters related to epigenetic modification (alcohol) as well as annotations related to development using a gene list generated by using age as an experimental factor; (2) the increased number of genes that were downregulated vs upregulated using alcohol as an independent variable; (3) the lack of a clear interaction effect between alcohol (prenatal vs control) and age at 5 months and 2 years; and (4) the emergence of EFNB1 as a candidate gene that might be related to some aspects of the phenotypic consistency and genetic vulnerability to PAE in humans. These four identifications will be discussed in further detail below.

We analyzed these data to assess the possibility of a disrupted molecular pathway using alcohol as an independent variable with the functional annotation tool DAVID 6.8. The full list of enriched clusters (found in the online data files) broadly implicates a wide variety of cellular processes with our top two clusters related to epigenetic modifications. These results must be interpreted carefully given the lower false discovery rate (FDR) assigned to them and also because this type of pathway exploration has been performed repeatedly without a clearly replicated pathway that is incontrovertibly linked to PAE [9,10,11,12,13,14,15,16,17,18]. Interestingly though, a recent meta-analysis [47] highlighted that despite the dissimilarity across studies, a gene set related to pathways involved in protein synthesis, mRNA splicing, and chromatin organization has emerged and our data, in part, replicates this finding.

Including age as an independent variable within our experimental design provided the opportunity to generate data that would produce results consistent with previously identified GO terms and annotation clusters related to development. In that sense, this experimental factor served as an experimental prediction and the results gave a strong indication of the face validity of the quality of the data. The importance of this predictive nature for one of the independent variables cannot be understated given the potential for gene expression studies, particularly related to PAE, to return unexpected and inconsistent pathway or enrichment results given the number of experimental combinations related to this phenotype.

The second benefit of using age as an independent variable is that it allowed us to explore the interaction between age and alcohol which informs us of whether the gene expression changes are chronic and are altered from the neonate stage through 2 years of simian development or whether they revert to levels observed in control animals as development proceeds through to the juvenile stage. Our results indicated that there is not a discernable interaction effect within our data set. This does not necessarily imply that the interaction effect is non-existent. This finding may stem from a small effect with a lack of statistical power which might have been corrected with larger sample size or the two age points selected for this study had not shown full differentiation in chronic gene expression related to alcohol.

We identified a relative difference in significantly downregulated genes vs upregulated genes in a roughly 2:1 ratio while examining alcohol as an independent variable that was not observed using age as an independent variable. This result is consistent with a recent meta-analysis revealing a systemic down regulation of genes influenced by alcohol [47]. A functional explanation for this observation could be related to an upper level of regulation such as epigenetic modifications or alteration in micro RNA (miRNA) expression levels. Interestingly, early studies into genome wide methylation patterns due to PAE in mice revealed global de-methylation [48]; however, more recently, it has been shown that this pattern is more consistent with demethylation and hyper-methylation depending on the region and the gene in question in both mice [49, 50], as well as in humans [51]. With respect to miRNA, there have been several groups that have already examined the effect of alcohol on miRNA expression in various animal models of FASD (as reviewed in [52]).

We further analyzed a subset of genes using qRT-PCR as a means to develop an independent validation of the results of the microarray analysis. The arrays themselves were highly correlated with each other and displayed very low fold changes, with zero of the genes using alcohol as an independent variable revealing fold changes greater than 2 (log2 = 1) and only 5 of the genes using age as an independent variable revealing fold changes greater than 2 (log2 = 1). Genes that display a fold changes < 2 are typically poor candidates for validation with qRT-PCR [53,54,55,56]. Despite this challenge, we replicated the fold changes in four of the five genes interrogated, including EFNB1. The fifth gene GBPB1L1 failed to replicate the fold changes; however, it had an inverse correlation with the expression data from the array and appears to have amplified a different vervet mRNA altogether (Supplemental Figure 8). The low fold changes for all of the genes on the array are consistent with expectations for monkeys that survived and continued through development as opposed to gene expression studies of cancerous tissue or acute challenges with ethanol.

The novel connection between EFNB1 and FASD provides some potentially exciting insight into the development of FASD as well as the clinical heterogeneity that this disorder presents. EFNB1 is a receptor tyrosine kinase [57] involved in a large variety of developmental processes such as cell migration, segmentation, and compartment boundary formation, axon guidance, topographic mapping, synaptogenesis, and angiogenesis [58, 59]. The Eph receptors are a family of genes that are critical in neurodevelopment, vascular development, and epithelial development via cell migration, adhesion and pattern formation [60,61,62]. In addition, EFNB1 regulates axon guidance [63] and plays a key role in synapse remodelling in the hippocampus [64, 65].

Purely due to its functional role in development, EFNB1 appears to be an interesting candidate gene for the development of FASD. Perhaps more striking is the resulting clinical presentation that occurs among individuals carrying a mutation in this gene. Loss of function mutations in EFNB1 lead to craniofronto-nasal syndrome (CFNS) a genetic condition characterized by a wide range of phenotypic effects including frontonasal dysplasia, craniofacial asymmetry, craniosynostosis, bifid nasal tip, grooved nails, wiry hair, and skeletal abnormalities [66,67,68]. There is a distinct degree of phenotypic overlap between classic FAS and CFNS. Furthermore, there is a wide range of atypical features observed in CFNS that have also been identified among individuals diagnosed with FASD including neurosensory hearing loss and cardiac defects [69,70,71].

Paradoxically, mutations in this X-linked gene affect females more severely than males, with females prone to the full range of effects while males typically suffer from hypertelorism [66]. The counterintuitive nature of this disorder appears to stem from “cellular interference” [72] that would occur during X-linked inactivation in females where the ephrin B1 signal is skewed across regional developmental boundaries. This skewing across boundaries leads to abnormal cell sorting and ectopic tissue boundaries [73, 74]. Support for this model for CFNS also stems from male children that are mosaic for EFNB1 mutations that display a more severe phenotype [75]. Interestingly, a genomic duplication of EFNB1 has been identified in a family segregating for X-linked hypertelorism indicating that development of abnormal craniofacial features is also sensitive to the expression level of this gene and not solely dependent on imbalanced signals across tissue boundaries stemming from mutations [76].

The mechanism of cellular interference and the differential expression by which this gene creates such a wide array of overlapping phenotypic features with FASD presents a plausible theoretical model that could reconcile many of the data that has been harvested with respect to FASD. It is well known that ethanol exerts tissue specific effects [77], particularly throughout the brain where it can lead to damaging effects in the hippocampus and frontal cortex [29, 78, 79]. The identification of EFNB1 presents the possibility that despite the broad mRNA downregulation and epigenetic changes across an array of molecular pathways, the phenotypic craniofacial signatures of classic FAS may emerge periodically from this cellular interference model of EFNB1 and the tissue specific effects of ethanol due to unbalanced EFNB1 expression levels across tissue boundaries.

The identification of EFNB1 presents a plausible model for some of the phenotypic features that tend to cluster in patients exposed to alcohol in utero, however caution is warranted until evidence from alternate lines of enquiry can be assimilated into a complete picture of this heterogeneous disorder.

Conclusions

The vervet monkey provides a powerful non-human primate model for studying the effects of prenatal alcohol exposure in a manner that more accurately reflects the changes that might be observed in humans while simultaneously allowing the generation of a carefully managed case/control environment. This study interrogated male monkeys exclusively to eliminate sex effects, and it is therefore possible that the effect on gene expression in female monkeys would reveal other interesting findings related to pre-natal alcohol exposure. The findings in this study support the frequently observed global downregulation of mRNA due to prenatal alcohol exposure and present a new hypothesis involving EFNB1 and a cellular interference model that could explain many of the frequently observed phenotypic patterns in humans associated with FASD.

Availability of data and materials

Raw data files (CEL files) as well as RMA normalized data have been uploaded to the gene expression omnibus website at the National Center for Biotechnology Information using minimum information for a microarray experiment (MIAME) guidelines GSE173516. In addition, all additional data utilized to generate conclusions within this experiment has been uploaded to the dryad database cited at the beginning of the supplemental materials.

Abbreviations

CFNS:

Cranio-frontal nasal syndrome

cRNA:

Complementary RNA

DAVID:

Database for annotation, visualization, and integrated discovery

FAS :

Fetal alcohol syndrome

FASD:

Fetal alcohol spectrum disorders

FDR:

False discovery rate

GO:

Gene ontology

miRNA:

Micro RNA

mRNA:

Messenger RNA

MUCQIC:

McGill University-Genome Quebec Innovation Center

NHP:

Non-human primate

PAE:

Prenatal alcohol exposure

qRT-PCR:

Quantitavie real-time polymerase chain reaction

RNA:

Ribonucleic acid

References

  1. Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973;1(7815):1267–71.

    CAS  PubMed  Google Scholar 

  2. Lemoine P, Harousseau, H., Borteyru, J.P., Menuet, J.C., 1968. Les enfants des parents alcoholiques; anomalies observees a propos de 127 cas. Quest Medical. 1968;25:476-82.

  3. Goulden KJ. Are FASD guidelines practical and sustainable? CMAJ. 2005;173(9):1070; author reply -1.

  4. Viljoen DL, Gossage JP, Brooke L, Adnams CM, Jones KL, Robinson LK, et al. Fetal alcohol syndrome epidemiology in a South African community: a second study of a very high prevalence area. J Stud Alcohol. 2005;66(5):593–604.

    PubMed  PubMed Central  Google Scholar 

  5. Streissguth AP, Dehaene P. Fetal alcohol syndrome in twins of alcoholic mothers: concordance of diagnosis and IQ. Am J Med Genet. 1993;47(6):857–61.

    CAS  PubMed  Google Scholar 

  6. Warren KR, Li TK. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol. 2005;73(4):195–203.

    CAS  PubMed  Google Scholar 

  7. Goodlett CR, Gilliam DM, Nichols JM, West JR. Genetic influences on brain growth restriction induced by development exposure to alcohol. Neurotoxicology. 1989;10(3):321–34.

    CAS  PubMed  Google Scholar 

  8. Gilliam DM, Kotch LE. Dose-related growth deficits in LS but not SS mice prenatally exposed to alcohol. Alcohol. 1996;13(1):47–51.

    CAS  PubMed  Google Scholar 

  9. Hard ML, Abdolell M, Robinson BH, Koren G. Gene-expression analysis after alcohol exposure in the developing mouse. J Lab Clin Med. 2005;145(1):47–54.

    CAS  PubMed  Google Scholar 

  10. Zhang C, Frazier JM, Chen H, Liu Y, Lee JA, Cole GJ. Molecular and morphological changes in zebrafish following transient ethanol exposure during defined developmental stages. Neurotoxicol Teratol. 2014;44:70–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. El Shawa H, Abbott CW 3rd, Huffman KJ. Prenatal ethanol exposure disrupts intraneocortical circuitry, cortical gene expression, and behavior in a mouse model of FASD. J Neurosci. 2013;33(48):18893–905.

    PubMed  PubMed Central  Google Scholar 

  12. Stringer RL, Laufer BI, Kleiber ML, Singh SM. Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders. Clin Epigenetics. 2013;5(1):14.

    PubMed  PubMed Central  Google Scholar 

  13. Kleiber ML, Laufer BI, Wright E, Diehl EJ, Singh SM. Long-term alterations to the brain transcriptome in a maternal voluntary consumption model of fetal alcohol spectrum disorders. Brain research. 2012;1458:18–33.

    CAS  PubMed  Google Scholar 

  14. Downing C, Flink S, Florez-McClure ML, Johnson TE, Tabakoff B, Kechris KJ. Gene expression changes in C57BL/6J and DBA/2J mice following prenatal alcohol exposure. Alcohol Clin Exp Res. 2012;36(9):1519–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Green ML, Singh AV, Zhang Y, Nemeth KA, Sulik KK, Knudsen TB. Reprogramming of genetic networks during initiation of the Fetal Alcohol Syndrome. Dev Dyn. 2007;236(2):613–31.

    CAS  PubMed  Google Scholar 

  16. Hashimoto-Torii K, Kawasawa YI, Kuhn A, Rakic P. Combined transcriptome analysis of fetal human and mouse cerebral cortex exposed to alcohol. Proc Natl Acad Sci U S A. 2011;108(10):4212–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Kimura KA, Chiu J, Reynolds JN, Brien JF. Effect of chronic prenatal ethanol exposure on nitric oxide synthase I and III proteins in the hippocampus of the near-term fetal guinea pig. Neurotoxicol Teratol. 1999;21(3):251–9.

    CAS  PubMed  Google Scholar 

  18. Mandal C, Park KS, Jung KH, Chai YG. Ethanol-related alterations in gene expression patterns in the developing murine hippocampus. Acta Biochim Biophys Sin (Shanghai). 2015;47(8):581–7.

    CAS  PubMed  Google Scholar 

  19. Lunde-Young R, Ramirez J, Naik V, Orzabal M, Lee J, Konganti K, et al. Hippocampal transcriptome reveals novel targets of FASD pathogenesis. Brain Behav. 2019;9(7):e01334.

    PubMed  PubMed Central  Google Scholar 

  20. Alberry BLJ, Castellani CA, Singh SM. Hippocampal transcriptome analysis following maternal separation implicates altered RNA processing in a mouse model of fetal alcohol spectrum disorder. J Neurodev Disord. 2020;12(1):15.

    PubMed  PubMed Central  Google Scholar 

  21. Ehrhart F, Roozen S, Verbeek J, Koek G, Kok G, van Kranen H, et al. Review and gap analysis: molecular pathways leading to fetal alcohol spectrum disorders. Mol Psychiatry. 2019;24(1):10–7.

    CAS  PubMed  Google Scholar 

  22. Howard RJ, Slesinger PA, Davies DL, Das J, Trudell JR, Harris RA. Alcohol-binding sites in distinct brain proteins: the quest for atomic level resolution. Alcohol Clin Exp Res. 2011;35(9):1561–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Freund G. Neurobiological relationships between aging and alcohol abuse. Recent Dev Alcohol. 1984;2:203–21.

    CAS  PubMed  Google Scholar 

  24. Korbo L. Glial cell loss in the hippocampus of alcoholics. Alcohol Clin Exp Res. 1999;23(1):164–8.

    CAS  PubMed  Google Scholar 

  25. White AM, Swartzwelder HS. Hippocampal function during adolescence: a unique target of ethanol effects. Annals of the New York Academy of Sciences. 2004;1021:206–20.

    CAS  PubMed  Google Scholar 

  26. Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol. 2007;29(1):141–52.

    CAS  PubMed  Google Scholar 

  27. Nagel BJ, Schweinsburg AD, Phan V, Tapert SF. Reduced hippocampal volume among adolescents with alcohol use disorders without psychiatric comorbidity. Psychiatry research. 2005;139(3):181–90.

    PubMed  PubMed Central  Google Scholar 

  28. Morris SA, Eaves DW, Smith AR, Nixon K. Alcohol inhibition of neurogenesis: a mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model. Hippocampus. 2010;20(5):596–607.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Livy DJ, Miller EK, Maier SE, West JR. Fetal alcohol exposure and temporal vulnerability: effects of binge-like alcohol exposure on the developing rat hippocampus. Neurotoxicol Teratol. 2003;25(4):447–58.

    CAS  PubMed  Google Scholar 

  30. Barnes DE, Walker DW. Prenatal ethanol exposure permanently reduces the number of pyramidal neurons in rat hippocampus. Brain research. 1981;227(3):333–40.

    CAS  PubMed  Google Scholar 

  31. McGoey TN, Reynolds JN, Brien JF. Chronic prenatal ethanol exposure-induced decrease of guinea pig hippocampal CA1 pyramidal cell and cerebellar Purkinje cell density. Can J Physiol Pharmacol. 2003;81(5):476–84.

    CAS  PubMed  Google Scholar 

  32. Burke MW, Ptito M, Ervin FR, Palmour RM. Hippocampal neuron populations are reduced in vervet monkeys with fetal alcohol exposure. Dev Psychobiol. 2015;57(4):470–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Lee AG, Hagenauer M, Absher D, Morrison KE, Bale TL, Myers RM, et al. Stress amplifies sex differences in primate prefrontal profiles of gene expression. Biol Sex Differ. 2017;8(1):36.

    PubMed  PubMed Central  Google Scholar 

  34. Palmour RM, Mulligan J, Howbert JJ, Ervin F. Of monkeys and men: vervets and the genetics of human-like behaviors. Am J Human Genetics. 1997;61(3):481–8.

    CAS  Google Scholar 

  35. Labonte B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, et al. Sex-specific transcriptional signatures in human depression. Nat Med. 2017;23(9):1102–11.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Ervin FR, Palmour RM, Young SN, Guzman-Flores C, Juarez J. Voluntary consumption of beverage alcohol by vervet monkeys: population screening, descriptive behavior and biochemical measures. Pharmacol Biochem Behav. 1990;36(2):367–73.

    CAS  PubMed  Google Scholar 

  37. Palmour RM, Ervin FR, Baker GB, Young SN. An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl). 1998;136(1):1–7.

    CAS  PubMed  Google Scholar 

  38. Association AVM. AVMA Guidelines for the Euthanasia of Animals. Schaumber, Il2013.

  39. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.

    PubMed  PubMed Central  Google Scholar 

  40. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–64.

    PubMed  Google Scholar 

  41. Blazejczyk M, Nadon. FlexArray: A statistical data analysis software for gene expression microarrays. 2007.

  42. Liu WM, Mei R, Di X, Ryder TB, Hubbell E, Dee S, et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics. 2002;18(12):1593–9.

    CAS  PubMed  Google Scholar 

  43. Stalteri MA, Harrison AP. Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. BMC Bioinformatics. 2007;8:13.

    PubMed  PubMed Central  Google Scholar 

  44. Miron M, Nadon R. Inferential literacy for experimental high-throughput biology. Trends Genet. 2006;22(2):84–9.

    CAS  PubMed  Google Scholar 

  45. Storey JD. A direct approach to false discovery rates. J Roy Stat Soc B. 2002;64:479–98.

    Google Scholar 

  46. Chen X, Robinson DG, Storey JD. The functional false discovery rate with applications to genomics. Biostatistics. 2021;22(1):68–81.

    PubMed  Google Scholar 

  47. Rogic S, Wong A, Pavlidis P. Meta-analysis of gene expression patterns in animal models of prenatal alcohol exposure suggests role for protein synthesis inhibition and chromatin remodeling. Alcohol Clin Exp Res. 2016;40(4):717–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Garro AJ, McBeth DL, Lima V, Lieber CS. Ethanol consumption inhibits fetal DNA methylation in mice: implications for the fetal alcohol syndrome. Alcohol Clin Exp Res. 1991;15(3):395–8.

    CAS  PubMed  Google Scholar 

  49. Laufer BI, Mantha K, Kleiber ML, Diehl EJ, Addison SM, Singh SM. Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice. Disease Models Mechanisms. 2013;6(4):977–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou FC. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics. 2009;4(7):500–11.

    CAS  PubMed  Google Scholar 

  51. Portales-Casamar E, Lussier AA, Jones MJ, MacIsaac JL, Edgar RD, Mah SM, et al. DNA methylation signature of human fetal alcohol spectrum disorder. Epigenetics Chromatin. 2016;9:25.

    PubMed  PubMed Central  Google Scholar 

  52. Balaraman S, Tingling JD, Tsai PC, Miranda RC. Dysregulation of microRNA expression and function contributes to the etiology of fetal alcohol spectrum disorders. Alcohol Res: Current Reviews. 2013;35(1):18–24.

    Google Scholar 

  53. Morey JS, Ryan JC, Van Dolah FM. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biological Procedures Online. 2006;8:175–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Wurmbach E, Yuen T, Sealfon SC. Focused microarray analysis. Methods. 2003;31(4):306–16.

    CAS  PubMed  Google Scholar 

  55. Etienne W, Meyer MH, Peppers J, Meyer RA Jr. Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques. 2004;36(4):618 -20, 22, 24-6.

    CAS  PubMed  Google Scholar 

  56. Rajeevan MS, Vernon SD, Taysavang N, Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Molecular Diagnostics : JMD. 2001;3(1):26–31.

    CAS  Google Scholar 

  57. Bruckner K, Pasquale EB, Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science. 1997;275(5306):1640–3.

    CAS  PubMed  Google Scholar 

  58. Wilkinson DG. Multiple roles of EPH receptors and ephrins in neural development. Nature Reviews Neurosci. 2001;2(3):155–64.

    CAS  Google Scholar 

  59. Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, et al. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Molecular cell. 2002;9(4):725–37.

    CAS  PubMed  Google Scholar 

  60. Beckmann MP, Cerretti DP, Baum P, Vanden Bos T, James L, Farrah T, et al. Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J. 1994;13(16):3757–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science. 1994;266(5186):816–9.

    CAS  PubMed  Google Scholar 

  62. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Current Opinion Cell Biol. 2004;16(5):580–9.

    CAS  PubMed  Google Scholar 

  63. Bush JO, Soriano P. Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. Genes Development. 2009;23(13):1586–99.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Nguyen AQ, Sutley S, Koeppen J, Mina K, Woodruff S, Hanna S, et al. Astrocytic Ephrin-B1 Controls Excitatory-Inhibitory Balance in Developing Hippocampus. J Neurosci. 2020;40(36):6854–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Koeppen J, Nguyen AQ, Nikolakopoulou AM, Garcia M, Hanna S, Woodruff S, et al. Functional Consequences of Synapse Remodeling Following Astrocyte-Specific Regulation of Ephrin-B1 in the Adult Hippocampus. J Neuroscience. 2018;38(25):5710–26.

    CAS  Google Scholar 

  66. Wieland I, Jakubiczka S, Muschke P, Cohen M, Thiele H, Gerlach KL, et al. Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Human Genetics. 2004;74(6):1209–15.

    CAS  Google Scholar 

  67. Wieland I, Weidner C, Ciccone R, Lapi E, McDonald-McGinn D, Kress W, et al. Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome. Clinical Genetics. 2007;72(6):506–16.

    CAS  PubMed  Google Scholar 

  68. Wallis D, Lacbawan F, Jain M, Der Kaloustian VM, Steiner CE, Moeschler JB, et al. Additional EFNB1 mutations in craniofrontonasal syndrome. Am J Med Genetics Part A. 2008;146A(15):2008–12.

    CAS  Google Scholar 

  69. Twigg SR, Kan R, Babbs C, Bochukova EG, Robertson SP, Wall SA, et al. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A. 2004;101(23):8652–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Kapusta L, Brunner HG, Hamel BC. Craniofrontonasal dysplasia. European journal of pediatrics. 1992;151(11):837–41.

    CAS  PubMed  Google Scholar 

  71. Goyal M, Pradhan G, Wieland I, Kapoor S. Craniofrontonasal syndrome: atrial septal defect with a novel EFNB1 gene mutation. The Cleft Palate-Craniofacial J. 2015;52(2):234–6.

    Google Scholar 

  72. Wieland I, Makarov R, Reardon W, Tinschert S, Goldenberg A, Thierry P, et al. Dissecting the molecular mechanisms in craniofrontonasal syndrome: differential mRNA expression of mutant EFNB1 and the cellular mosaic. Eur J Human Genet. 2008;16(2):184–91.

    CAS  Google Scholar 

  73. Wieacker P, Wieland I. Clinical and genetic aspects of craniofrontonasal syndrome: towards resolving a genetic paradox. Mol Genet Metab. 2005;86(1-2):110–6.

    CAS  PubMed  Google Scholar 

  74. Niethamer TK, Larson AR, O'Neill AK, Bershteyn M, Hsiao EC, Klein OD, et al. EPHRIN-B1 Mosaicism Drives Cell Segregation in Craniofrontonasal Syndrome hiPSC-Derived Neuroepithelial Cells. Stem Cell Reports. 2017;8(3):529–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Twigg SR, Babbs C, van den Elzen ME, Goriely A, Taylor S, McGowan SJ, et al. Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. Hum Mol Genet. 2013;22(8):1654–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Babbs C, Stewart HS, Williams LJ, Connell L, Goriely A, Twigg SR, et al. Duplication of the EFNB1 gene in familial hypertelorism: imbalance in ephrin-B1 expression and abnormal phenotypes in humans and mice. Human Mutation. 2011;32(8):930–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Maier SE, West JR. Regional differences in cell loss associated with binge-like alcohol exposure during the first two trimesters equivalent in the rat. Alcohol. 2001;23(1):49–57.

    CAS  PubMed  Google Scholar 

  78. Idanpaan-Heikkila J, Jouppila P, Akerblom HK, Isoaho R, Kauppila E, Koivisto M. Elimination and metabolic effects of ethanol in mother, fetus, and newborn infant. Am J Obstet Gynecol. 1972;112(3):387–93.

    CAS  PubMed  Google Scholar 

  79. Burke MW, Palmour RM, Ervin FR, Ptito M. Neuronal reduction in frontal cortex of primates after prenatal alcohol exposure. Neuroreport. 2009;20(1):13–7.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Amy Beierschmitt, DVM, and Denise Huggins for excellent animal care and research assistance. This work would not have been possible without the initiation of the prenatal alcohol studies by Frank R Ervin, MD (now deceased) and by financial support from the Canadian Institute of Health Care and Behavioural Science Foundation, St. Kitts. The hybridization of the arrays was carried out at the McGill University and Genome Quebec Innovation Center. We would also like to thank Robert Nadon for his consultation regarding the statistical analysis and Jacek Majewski for his helpful consultation throughout the project.

Funding

This study was funded using a grant from the Canadian institute of health research (CIHR) MOP 57899. The CIHR had no role in the design, collection, analysis, or interpretation of the data contained within the manuscript.

Author information

Authors and Affiliations

  1. Department of Human Genetics, McGill University, Montreal, Canada

    Rob F. Gillis & Roberta M. Palmour

  2. Department of Psychiatry, McGill University, Montreal, Canada

    Roberta M. Palmour

  3. Behavioural Science Foundation, St. Kitts, Federation of St Kitts and Nevis, Montreal, Canada

    Roberta M. Palmour

Authors
  1. Rob F. Gillis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta M. Palmour
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RF Gillis assisted in sample collection, performed the data analysis, wrote and prepared the manuscript. RM Palmour collected samples, funded this study, created the study design, and edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Roberta M. Palmour.

Ethics declarations

Ethics approval and consent to participate

All procedures in this study were reviewed and approved by the Animal Care Committees of the Behavioural Science Foundation and of McGill University (Montreal, Canada protocol #4627), both acting under the protocol established of the Canadian Council on Animal Care. The methods utilized for sacrificed were approved by the American veterinary medical association.

Consent for publication

Not applicable

Competing interests

RF Gillis declares that he has no competing interest. Roberta Palmour declares that she is the scientific officer (unpaid) for the Behavioural Science Foundation, a not-for-profit research foundation registered in the State of Delaware (USA).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplemental Figure 1.

RNA degradation plots showing 5’-3’ mean intensity levels for all 24 arrays revealing a similar slope across all samples without any major outliers as a result of 5’-3’ degradation. Supplemental Figure 2. Principal component analysis (PCA) of all 24 arrays for the unique expressed probe sets that remained after culling for annotation, multiple probe sets and MAS5 calls. Twenty-two arrays grouped together with FASD5_1 and FASD2_5 showing a distinct expression pattern which skews and distinguishes them from the other arrays due to non-technical variance. These arrays were excluded from further analyses to avoid skewing the group means due to variance unrelated to experimental factors. Supplemental Figure 3. 3D PCA plot of expression post normalization via RMA after exclusion of FASD5_1 and FASD2_5 revealing the unsupervised organization of the 22 remaining samples. Supplemental Figure 4. Box plots of GeneChip Rhesus Macaque genome array expression data for all 24 arrays after RMA normalization. Supplemental Figure 5. Histogram of p-value distributions for Alcohol divided into 20 bins with each bin representing 0.05 units. The distribution shows a distinct and sharp increase in the 0-0.05 bin indicating that Alcohol as an experimental factor resulted in a higher number of differentially expressed genes than would have been predicted under the null hypothesis. The black shaded bar represents the most frequent bin within the distribution. Supplemental Figure 6. Histogram of p-value distributions using Age as a main effect divided into 20 bins with each bin representing 0.05 units of distribution. The distribution shows a distinct and sharp increase in the 0-0.05 bin indicating that Age as an experimental factor resulted in a higher number of differentially expressed genes than would have been predicted under the null hypothesis. The black shaded bar represents the most frequent bin within the distribution. Supplemental Figure 7. Histogram of p-value distributions for the interaction between Age and Alcohol divided into 20 bins with each bin representing 0.05 units. The distribution shows a flat distribution indicating there is no evidence for a generalized genome wide interaction effect between these two experimental factors. The black shaded bar represents the most frequent within the distribution. Supplemental Figure 8. Correlation of log2 expression intensity and -delta Ct values using ACTB to normalize expression values. GBPB1L1 strays from the trend line implying that it may have amplified a target region not represented by the probe set. Supplemental Table 1. Mean intensity/expression levels (log2) and mean variance for all 11,512 mRNA for all four groups involved in this study. Supplemental Table 2. Primer sequences used for qRT-PCR amplification of selected genes taken from the Rhesus GeneChip array. Supplementary Table 3. Functional annotation results using the 297 genes which returned the lowest p-values using Age as a main effect. Eight of the 15 top annotation clusters returned results related to development or cell migration with lower overall p-values and FDR values when compared to those generated using alcohol as a main effect.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gillis, R.F., Palmour, R.M. mRNA expression analysis of the hippocampus in a vervet monkey model of fetal alcohol spectrum disorder. J Neurodevelop Disord 14, 21 (2022). https://doi.org/10.1186/s11689-022-09427-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s11689-022-09427-z

Keywords

  • Fetal alcohol spectrum disorders
  • Gene expression analysis
  • Neurodevelopment
  • Non-human primate model

Journal of Neurodevelopmental Disorders

ISSN: 1866-1955

Contact us